Details for 2019194203
Up to date per 26.04.2026
Actions
Details for 2019194203
Granted/Registered
European Patent
01.04.2020 A
14.09.2022 B1
31.01.2014
US
201461934619 P
27.03.2014
US
201461971009 P
A61K 39/00 20060101AFI20210923BHEP
Owner
Cytomx Therapeutics Inc.151 Oyster Point Boulevard, Suite 400 South San Francisco, CA 94080US
Representative
No representatives present
Inventor
MOORE, Stephen James218 Country Meadows Lane Danville, CA 94506US
NGUYEN, Margaret Thy Luu1176 Pusateri Way San Jose, CA 95121US
HOSTETTER, Daniel R.3909 Park Blvd. Palo Alto, CA 94306US
VASILJEVA, Olga20080 Rodrigues Avenue D Cupertino, CA 95104US
Information about Fees